Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04169802 · ClinicalTrials.gov registry record
Study Evaluating Retinal Health Monitoring System Visual Acuity Module.
A clinical trial of Age-related Macular Degeneration, sponsored by Kubota Vision.
- Completed
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT04169802 is a study of Age-related Macular Degeneration that has completed, run by Kubota Vision. The registered enrollment target is 25 participants, below the 1,507-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04169802, a study of Age-related Macular Degeneration, has completed, sponsored by Kubota Vision.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Assess the performance and usability of the RHMS Visual Acuity Module.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Retinal Health Monitoring System Visual Acuity Module
- DIAGNOSTIC_TEST Sloan letter, logarithmic near visual acuity chart (Reference Chart)
Study Locations (1)
Arizona
- Retina Consultants of Arizona - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-11-20 |
| Est. Completion | 2020-04-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04169802
The ClinicalTrials.gov registry entry for NCT04169802 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,507-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (98% lower). The listed sponsor is Kubota Vision, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 2 interventions - of which Retinal Health Monitoring System Visual Acuity Module is the first listed.
NCT04169802 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT04169802 about?
NCT04169802 is a clinical study titled "Study Evaluating Retinal Health Monitoring System Visual Acuity Module.". Assess the performance and usability of the RHMS Visual Acuity Module.
What is the current status of trial NCT04169802?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2019-11-20. Estimated completion is 2020-04-15.
What conditions does trial NCT04169802 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration.
What interventions are being tested in trial NCT04169802?
The interventions under investigation include: Retinal Health Monitoring System Visual Acuity Module (DIAGNOSTIC_TEST), Sloan letter, logarithmic near visual acuity chart (Reference Chart) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04169802?
This trial is sponsored by Kubota Vision, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04169802 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
RECRUITING · Phase 2
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
High Resolution Retinal Imaging
RECRUITING
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RECRUITING · Phase 1
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.